Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Neuropharmacology|June 20, 2006
Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosisJudith A Siuciak, Douglas S Chapin, John F Harms, et al.Journal of Medicinal Chemistry|January 11, 1991
Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram bindingF J Vinick, N A Saccomano, B K Koe, et al.The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETON Da Silva, S Meyer-Monard, M L Menot, et al.Bioorganic & Medicinal Chemistry Letters|July 7, 2009
Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonistsChristopher J O'Donnell, Langu Peng, Brian T O'Neill, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.Frontiers in Human Neuroscience|February 3, 2016
Fear and Reward Circuit Alterations in Pediatric CRPSLaura E Simons, Nathalie Erpelding, Jessica M Hernandez, et al.Journal of Medicinal Chemistry|August 1, 1990
3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indoleJ E Macor, C A Burkhart, J H Heym, et al.Journal of Medicinal Chemistry|February 1, 1991
Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesteraseJ A Lowe, R L Archer, D S Chapin, et al.Neurobiology of Pain (Cambridge, Mass.)|January 1, 2020
Biological and behavioral markers of pain following nerve injury in humansS A Holmes, N Barakat, M Bhasin, et al.Journal of Medicinal Chemistry|January 19, 2007
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitorsThomas A Chappie, John M Humphrey, Martin P Allen, et al.Pageof 7